These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7519841)

  • 41. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1997 Jun; 115(6):741-7. PubMed ID: 9194725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Occult choroidal neovascularization in age-related macular degeneration. A natural history study.
    Stevens TS; Bressler NM; Maguire MG; Bressler SB; Fine SL; Alexander J; Phillips DA; Margherio RR; Murphy PL; Schachat AP
    Arch Ophthalmol; 1997 Mar; 115(3):345-50. PubMed ID: 9076206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Digital indocyanine-green videoangiography of occult choroidal neovascularization.
    Guyer DR; Yannuzzi LA; Slakter JS; Sorenson JA; Hope-Ross M; Orlock DR
    Ophthalmology; 1994 Oct; 101(10):1727-35; discussion 1735-7. PubMed ID: 7524004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diode laser photocoagulation of choroidal neovascular membranes.
    Lanzetta P; Virgili G; Menchini U
    Int Ophthalmol; 1995-1996; 19(6):347-54. PubMed ID: 8970868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of the macular photocoagulation study results on the treatment of exudative age-related macular degeneration.
    Moisseiev J; Alhalel A; Masuri R; Treister G
    Arch Ophthalmol; 1995 Feb; 113(2):185-9. PubMed ID: 7532394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial.
    Maguire MG; Alexander J; Fine SL;
    Ophthalmology; 2008 Sep; 115(9):1468-73, 1473.e1-2. PubMed ID: 18486222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study.
    Bergink GJ; Deutman AF; van den Broek JF; van Daal WA; van der Maazen RW
    Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):591-8. PubMed ID: 7528158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Choroidal neovascularization in second eyes of patients with unilateral exudative age-related macular degeneration.
    Chang B; Yannuzzi LA; Ladas ID; Guyer DR; Slakter JS; Sorenson JA
    Ophthalmology; 1995 Sep; 102(9):1380-6. PubMed ID: 9097777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of choroidal neovascularization in age-related macular degeneration with fluorescein and indocyanine green videoangiography.
    Atmaca LS; Batioğlu F; Atmaca P
    Ophthalmologica; 1996; 210(3):148-51. PubMed ID: 8738457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of exudative age-related macular degeneration].
    Yuzawa M
    Nippon Ganka Gakkai Zasshi; 2000 Dec; 104(12):875-98. PubMed ID: 11193943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Presence or absence of choroidal hyper-transmission by SD-OCT imaging distinguishes inflammatory from neovascular lesions in myopic eyes.
    Shi X; Cai Y; Luo X; Liang S; Rosenfeld PJ; Li X
    Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):751-758. PubMed ID: 31907643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Scanning laser fundus perimetry before laser photocoagulation of well defined choroidal neovascularisation.
    Rohrschneider K; Glück R; Becker M; Holz FG; Kruse FE; Fendrich T; Völcker HE
    Br J Ophthalmol; 1997 Jul; 81(7):568-73. PubMed ID: 9290371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ANTIANGIOGENICS IN CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH LASER IN CENTRAL SEROUS CHORIORETINOPATHY.
    Chhablani J; Pichi F; Silva R; Casella AM; Murthy H; Banker A; Nowilaty SR; Carrai P; Nucci P; Arevalo JF;
    Retina; 2016 May; 36(5):901-8. PubMed ID: 27115855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiation therapy for ocular choroidal neovascularization (phase I/II study): preliminary report.
    Sasai K; Murata R; Mandai M; Takahashi M; Ogura Y; Ngata Y; Nishimura Y; Hiraoka M
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):173-8. PubMed ID: 9300752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
    Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
    Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current management of choroidal neovascularization.
    Singerman LJ
    Ann Ophthalmol; 1988 Nov; 20(11):415-20, 423. PubMed ID: 2466432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser.
    Friberg TR; Karatza EC
    Ophthalmology; 1997 Dec; 104(12):2030-8. PubMed ID: 9400762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical observations supporting a theoretical model of choriocapillaris blood flow in treatment of choroidal neovascularization associated with age-related macular degeneration.
    Staurenghi G; Flower RW
    Am J Ophthalmol; 2002 Jun; 133(6):801-8. PubMed ID: 12036672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
    Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.